Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Pediatric patients who adopted and sustained a CD exclusion diet achieved clinical remission and reported improvement in clinical symptoms and fecal calprotectin.
Biocon Biologics launches YESINTEK (ustekinumab-kfce), a biosimilar for Crohn's disease, ulcerative colitis, plaque psoriasis ...
Larry Sears and Sally Zlotnick Sears recently donated $1 million to the Crohn’s and Colitis Foundation, according to a news release.
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
YESINTEK is a monoclonal antibody that disrupts IL-12 and IL-23 mediated signaling associated immune mediated diseases.
Hosted on MSN16h
Celltrion booth at inflammatory bowel disease research gatheringCelltrion booth at inflammatory bowel disease research gathering Visitors look at a poster of South Korean pharmaceutical ...
Bradford-born magician Steven Frayne - formerly known as Dynamo - has spoken of his struggles with Crohn's disease.
A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...
Steven Frayne, formerly known as the illusionist and magician Dynamo, said he hoped Bradford's City of Culture year would ...
Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then, he's found a way to manage the disease with treatment and a strict diet.
SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results